Marc Odrich's most recent trade in LENZ Therapeutics Inc. was a trade of 80,100 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LENZ Therapeutics Inc. | Marc Odrich | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 80,100 | 80,100 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc. | Marc Odrich | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 105,000 | 105,000 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc. | Marc Odrich | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 99,599 | 99,599 | - | 0 | Common Stock | |
| LENZ Therapeutics Inc. | Marc Odrich | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 66,472 | 66,472 | - | - | Stock Option (right to buy) |